Interestingly, when the NY8.3 TCR transgene is crossed to a RAG2-deficient NOD background, the mice, which have only NY8.3 CD8 T cells and no CD4 T cells, develop diabetes less frequently and significantly later than do RAG-2-sufficient NY8.3 TCR transgene NOD mice. This evidence concerns the gene RAG2 and diabetes mellitus.